TEVA · Teva Pharmaceutical Industries Ltd.
AI read · Good for TEVA
The AI's read
This approval lets IGALMI be used outside a healthcare setting, opening a new way for Teva to offer the treatment. The Phase 3 trial met its safety and tolerability goal, supporting the change. Teva has not shared its plans to sell the at-home version, so its sales contribution is not yet known.